Results 61 to 70 of about 9,484 (203)

Preoperative and Intraoperative Risk Factors for Short‐Term Corneal Endothelial Cell Loss After Phacoemulsification in Dogs: A Comparative Study

Veterinary Ophthalmology, Volume 29, Issue 2, March 2026.
ABSTRACT Objective To investigate the short‐term impact of phacoemulsification on corneal endothelial cells and corneal thickness and identify associated risk factors. Animal Studied Twenty‐four dogs (33 eyes) scheduled for phacoemulsification to treat cataracts were evaluated.
Tae‐Won Yoon, Joon‐Young Kim
wiley   +1 more source

Ocular Hypotensive Effect of ONO-9054, an EP3/FP Receptor Agonist: Results of a Randomized, Placebo-controlled, Dose Escalation Study [PDF]

, 2016
Purpose: To assess pharmacodynamic and safety profiles of ONO-9054 following single and multiple day dosing in subjects with ocular hypertension or open-angle glaucoma.
Fujii, Akifumi, Harris, Alon, Ouchi, Takafumi, Rowe-Rendleman, Cheryl L., Serle, Janet B., Ward, Caroline L., Wood, Andrew   +6 more
core   +1 more source

Topical Omidenepag Isopropyl Lowers Intraocular Pressure in Normal and Glaucomatous Cats: A Pilot Study

Veterinary Ophthalmology, Volume 29, Issue 2, March 2026.
ABSTRACT Purpose To evaluate the effects of topical prostaglandin E2 receptor 2 (EP2) agonist, omidenepag isopropyl (OMDI), on intraocular pressure (IOP) and pupil diameter (PD) in normal cats and cats with feline congenital glaucoma (FCG). Animals Studied Ten FCG cats and 8 normal cats.
Kazuya Oikawa, Julie A. Kiland, Hayden G. Zaluckyj, Anjali Rai, Virginia Mathu, Gillian J. McLellan   +5 more
wiley   +1 more source

Management of angle closure glaucoma [PDF]

, 2011
10.4103/0301-4738.73690Indian Journal of Ophthalmology59SUPPL.
See, J., Aquino, M.C., Aduan, J., Chew, P.   +3 more
core   +1 more source

Efficacy and safety of benzalkonium chloride-free fixed-dose combination of latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension

Clinical Ophthalmology, 2014
Purvi Bhagat,1 Kalyani Sodimalla,2 Chandrima Paul,3 Surinder S Pandav,4 Ganesh V Raman,5 Rengappa Ramakrishnan,6 Abhijeet Joshi,7 Atul Raut7 1Glaucoma Clinic, M & J Western Regional Institute of Ophthalmology, Civil Hospital, Ahmedabad, Gujarat ...
Bhagat P, Sodimalla K, Paul C, Pandav SS, Raman GV, Ramakrishnan R, Joshi A, Raut A   +7 more
doaj  

Evaluation of Visual Field and Imaging Outcomes for Glaucoma Clinical Trials (An American Ophthalomological Society Thesis) [PDF]

, 2017
PURPOSE: To evaluate the ability of various visual field (VF) analysis methods to discriminate treatment groups in glaucoma clinical trials and establish the value of time-domain optical coherence tomography (TD OCT) imaging as an additional outcome ...
Cheng, Q., Crabb, D. P., Garway-Heath, D. F., Prah, P., Quartilho, A., Zhu, H.   +5 more
core   +1 more source

Implantable Drug Delivery Systems for Skeletal Muscles and Eyes

Advanced NanoBiomed Research, Volume 6, Issue 2, February 2026.
This review highlights the different types of recent implantable drug delivery systems (IDDS) fabricated for a use with skeletal muscles, and with eyes. It presents the developments already made and the current research directions, showing the evolution of IDDS and their great diversity.
Serge Ostrovidov, Murugan Ramalingam, Hongkai Wu, Toshinori Fujie, Yukinari Nakamura, Takeshi Hori, Yuji Nashimoto, Xuetao Shi, Hirokazu Kaji   +8 more
wiley   +1 more source

Efficacy and safety of timolol and latanoprost in the treatment of primary open-angle glaucoma

National Journal of Physiology, Pharmacy and Pharmacology, 2017
Background: Glaucoma is a chronic, progressive optic neuropathy which leads to optic nerve damage and loss of visual function. Elevated intraocular pressure (IOP) is the most important and only modifiable risk factor.
Soumya Ratnala, Jayanthi C R, Sujatha B L   +2 more
doaj   +1 more source

Statement from the frontal fibrosing alopecia international expert alliance: SOFFIA 2024

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 2, Page 210-223, February 2026.
Optimal treatment for frontal fibrosing alopecia (FFA) remains contentious. An international expert panel agreed that highly/ultra‐potent topical steroids were the preferred first‐line topical therapy. Preferred systemic therapies were 5‐alpha reductase inhibitors, followed by hydroxychloroquine.
Nekma Meah, Jane Li, Dmitri Wall, Katherine York, Bevin Bhoyrul, Laita Bokhari, Lachlan Coulthard, Leila Asfour, Leonardo Spagnol Abraham, Daniel Asz‐Sigall, Wilma F. Bergfeld, Regina C. Betz, Ulrike Blume‐Peytavi, Valerie Callender, Vijaya Chitreddy, Andrea Combalia, George Cotsarelis, Brittany Craiglow, Rachita Dhurat, Ncoza Dlova, Jeff Donovan, Andrei Doroshkevich, Samantha Eisman, Paul Farrant, Aida Gadzhigoroeva, Jack Green, Ramon Grimalt, Matthew Harries, Maria Hordinsky, Alan D. Irvine, Victoria Jolliffe, Spartak Kaiumov, Brett King, Steven Kossard, Joyce Lee, Won‐Soo Lee, Nino Lortkipanidze, Amy McMichael, Natasha Atanaskova Mesinkovska, Andrew Messenger, Paradi Mirmirani, Elise Olsen, Seth J. Orlow, Yuliya Ovcharenko, Bianca Maria Piraccini, Rodrigo Pirmez, Adriana Rakowska, Pascal Reygagne, Janet Roberts, Lidia Rudnicka, David Saceda‐Corralo, Jerry Shapiro, Pooja Sharma, Tatiana Silyuk, Poonkiat Suchonwanit, Anita Takwale, Antonella Tosti, W. I. Visser, Sergio Vañó‐Galván, Annika Vogt, Martin Wade, Leona Yip, Abraham Zlotogorski, Cheng Zhou, Rodney Sinclair   +64 more
wiley   +1 more source

Are Patient Self-Reported Outcome Measures Sensitive Enough to Be Used as End Points in Clinical Trials?: Evidence from the United Kingdom Glaucoma Treatment Study [PDF]

, 2018
Purpose The United Kingdom Glaucoma Treatment Study (UKGTS) demonstrated the effectiveness of an intraocular pressure-lowering drug in patients with glaucoma using visual field progression as a primary outcome.
Amalfitano, F., Anand, N., Azuara-Blanco, A., Bourne, R., Broadway, D. C., Bunce, C., Crabb, D. P., Cunliffe, I. A., Diamond, J. P., Fraser, S. G., Garway-Heath, D. F., Ho, T. A., Jones, L., Lascaratos, G., Martin, K. R., McNaught, A., Negi, A., Patel, K., Russell, R. A., Shah, A., Spry, P. G., Suzuki, K., White, E.T., Wormald, R., Xing, W., Zeyen, T. G.   +25 more
core   +1 more source